Aflibercept biosimilar (Kidswell Bio)

阿柏西普生物类似药 (Kidswell Bio)

Report date: 2024/02/05 16:46:51

Base Information

Drug NameAflibercept biosimilar (Kidswell Bio)

Drug Alias NameGBS-012

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion proteinBiologics > Biosimilar

Mechanisms of ActionVascular endothelial growth factor A inhibitorsPlacental Growth Factor inhibitors

TargetsVascular endothelial growth factor APlacental Growth Factor

Therapy Area/IndicationsEye Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGene Techno Science

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsEye Diseases

Inactive IndicationsN/A

ATC CodeN/A